Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
NextGen Omics & Data 2025 Logo (White)

13 - 14 November 2025 | London, UK

Bringing together 1000+ key scientific researchers, pharma & healthcare leaders under one roof to accelerate multi-omics approaches to various disease at our NGS & Clinical Diagnostics, Multi-omics in Single Cell and Spatial Analysis programmes

Overview NGS & Clinical Diagnostics Multi-Omics in Single Cell & Spatial Analysis

Welcome to NextGen Omics & Data 2025, Oxford Global’s Flagship Multi-Omics Meeting

Bringing together key scientific leaders representing renowned academic and healthcare organizations, as well as pharmaceutical and biotech companies, to discuss the latest scientific and technological advancements through a 2-day programme.

Our combined agenda, which include our NGS & Clinical Diagnostics and Multi-Omics in Single Cell and Spatial Analysis programmes offer a one-stop-shop platform for multi-omics approaches via cutting-edge presentations and C-level interactive sessions, bridging the gap between fundamental omics research and real-life applications in drug development and diagnostics. Do not miss out on experiencing leading-edge science to stay ahead of upcoming breakthroughs predicted to impact the next-generation multi-omics market. 

NGS & Clinical Diagnostics 2025

  • Hear from and meet with the key innovators in multi-omics. 2024 attendees included: Senior Director, Bioinformatics Astex; Executive Director, Computational Biology, Sanofi; Director, NGS/ Transcriptomics, AstraZeneca
  • Discuss the advancements in clinical genomics. Presentations will include applying genome sequencing to disease prevention, reproducibility & validation of variants, real world clinical applications and metagenomics analysis developments
  • New to 2025! Take a deep dive into data harmonisation, integration and analysis. Presentations will include tools for analysing high-throughput sequencing data, large-scale multi-omics data analysis and AI/ML toolkits for multi-omics datasets  
  • New to 2025! Join key opinion leaders to advance AI/ML-based approaches in multi-omics to advance clinical trials & personalised treatments
  • Engage in thought-provoking panel discussions, roundtables & workshops on the latest developments, emerging innovations & novel technologies in multi-omics research. Discussion sessions include: Genomic approaches for diagnosing patients with rare diseases; NGS & clinical data methods, approaches, and platforms for data integration; Integrating multi-omics data for adaptive trial designs.

Agenda at a Glance

Day One

Track 1: Clinical Genomics
Track 2: Multi Omic Data Analysis, Integration, & Harmonisation

Day Two

Track 1: NGS Applications in the Clinic for Diagnostics Development 
Track 2: Clinical Genomics Applications in Hospitals for Newborn Screening & Diagnosis
Track 3: Advances in Omics and Big Data  

Multi-Omics in Single Cell & Spatial Analysis 2025

  • Hear from and meet with the key innovators in single cell & spatial biology. 2025 attendees include, VP / Director of Computational Biology, Bioinformatics, NGS/ Transcriptomics & Professor of Computational Genomics / genetics/ computational sciences
  • New to 2025! Advance your understanding emerging of single cell technologies from novel technologies for single cell imaging, through to one pot assays, benchmarking single cell technologies and updates from single cell multi-omics, applying omics in the clinic, bioinformatics for single cell analysis and clinical genomics update
  • Discuss the latest innovations in spatial multi-omics tools, techniques & approaches and learn how it is poised to fuel the next wave of biomedical innovation. Presentations will delve into translating spatial imaging techniques & approaches into the clinic, multi-modality processing and case studies from various spatial multi-omics
  • New to 2025! Take a deep dive into data harmonisation, integration and analysis. Presentations will include tools for analysing high-throughput sequencing data, large-scale multi-omics data analysis and AI/ML toolkits for multi-omics datasets  
  • New to 2025! Gain comprehensive insights into utilising spatial biology in pharma. Hear how Spatial Biology is driving forward biomarker and drug target discovery as well as diagnostic and therapeutic innovation with its impact on disease research and ability to enable a tailored precision medicine approach
  • Overcome the research challenges you face. Learn how experts are overcoming barriers in acquiring and analysing spatial data and how they are navigating the computational complexities of processing and turning datasets into understandable interpretable knowledge

Agenda at a Glance

Day One

Track 3: AI-Guided Single Cell Analysis: Advanced Tools & Technologies
Track 4: Multi-Omics-Guided Single Cell Analysis Across Modalities – Emerging Tools & Technologies
Track 5: Applications of Spatial Technologies in the Clinic
Track 6: Spatial Multi-Omics and Imaging in Drug Discovery

Day Two

Track 4: Single Cell Analysis in Translational Drug Development
Track 5: Multi Omic Data Integration, Harmonisation & Analytics for Single Cell & Spatial Analysis
Track 6: Applications of Spatial Research & Technologies in Biology

NextGen Biomed 2025

Advancing Therapeutic Innovation Through Multi-Omics Research  

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. 

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

Hear from past attendees of last year's Biologics 2024 conference

Explore the NextGen Omics & Spatial Biology US 2025 Programme

Antibody Society

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society

What to Expect at NextGen Omics & Data 2025

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative program there are over 700 pre-arranged 1-2-1 meetings and over 12 hours of networking solutions. Don't miss the opportunity to connect with 1000 leaders from across pharma, biotech, regulatory and academia.

Engaging Thought Leadership
Experience a variety of interactive discussions, thought leadership debated, & collaborative roundtables, with insights from industry leaders on key developments and pain points in the advancement of multi-omics.

Global Technology Showcase
An international exhibition showcasing cutting-edge technologies & services from premier providers in the scientific field.

Networking Emphasis
Unparalleled networking opportunities, including personalised 1-2-1 meetings, a vibrant drinks reception, and informal gatherings to foster meaningful connections.

NextGen Biomed - What to Expect Exhibiting 2
NextGen Biomed - What to Expect Exhibiting 3
NextGen Biomed - What to Expect Poster 2
1000

leading pharma, biotech, regulatory & academic delegates

700
pre-arranged 1-2-1 meetings, facilitating business growth
50
hours of presentations, discussions & interactive content
12
hours of networking breaks, including fireside chats & refreshments

NextGen Multi-Omics 2025 Programme Highlights

Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:

NGS, CLINICAL OMICS & DIAGNOSTICS 
Panel Discussion: Overcoming Multi-Omics Data Harmonisation & Analysis Challenges 

Moderator: Ruslan Sadreyev, Director of Bioinformatics & Assistant Professor, Massachusetts General Hospital 
Panellists: Aridaman Pandit, Senior Principal Research Scientist, Abbvie; Felix Francis, Sr. Manager, Data Management and Analytics Technology Lead, Takeda; Luca Pinello, Associate Professor of Pathology, Harvard Medical School 

NGS, CLINICAL OMICS & DIAGNOSTICS
Presentation: An Update On Global Genomics & Diagnostics Policy  

Presented by: Virginia Acha, AVP Global Regulatory Policy & Intelligence, MSD

SINGLE CELL 
Panel Discussion: Single Cell Multi-Omics Integration – From The Pharma Perspective 

Panellists: Tao Yang, Director of Computational Biology, Eli Lilly 

SPATIAL MULTI-OMICS
Roundtable Discussion: Safety Biomarkers in the age of Spatial Biology    

Moderator: Marina Bleck, Principal Scientist, Boehringer Ingelheim 

SPATIAL MULTI-OMICS 
Workshop: Spatial Genomics & Transcriptomics to Investigate Tumor Biology  Chronic Disease Immunotherapies?

Two presentations followed by a panel discussion with insights from Yasser Riazalhosseini, Associate Professor & Head of Cancer Genomics, McGill University 
Stephen Wong, Department Chair & Centre Director Houston Methodist Hospital, Professor at Cornell Medical College 

Speakers

Key Speakers of NextGen Omics 2024 Included:

Bozena Kaminska
Professor,
Nencki Institute of Experimental Biology
Harpreet Saini
Senior Director,
Astex Pharmaceuticals
Isabelle Bergiers
Senior Scientist,
Janssen Pharmaceutical Companies of Johnson & Johnson
Luigi Aloia
Associate Director,
AstraZeneca
Michael Oellerich
Research Professor,
Georg-August-Universität Göttingen
Michael Cook
Executive Director of Science,
Our Future Health
Nicolas Kuperwasser
Director,
Necker Infants Hospital Paris
Robert Brucker
Chief Scientific Officer & Co-Founder,
DermBiont
Sophia Tsoka
Reader in Bioinformatics,
King's College London
Tootie Bueser
Director of Nursing & Midwifery,
Incisive Health, NHS
Ahmad Khodr
Head of the Microbiology Innovation Lab,
L'Oréal Research and Innovation
Aidan Nickerson
Discovery Data Scientist,
Eli Lilly
Aikaterini Gatsiou
Assistant Professor,
Lancaster University
Alain Wagner
Director of BioFunctional Chemistry Lab,
University of Strasbourg
Aleksandra Gruevska
Research Associate,
Imperial College London
Basel Abu- Jamous
Director of Computational Biology,
Nucleome Therapeutics
Bernhard Schmierer
Head of the CRISPR Functional Genomics Unit,
Karolinska Institute
Bin Yan
Higher Scientist,
National Physical Laboratory
Christian Kolter
Associate Director & Senior Principal Data Scientist,
Novartis
Christos Proukakis
Professor of Neurology and Neurogenetics,
University College London
Conceição Bettencourt
Senior Research Fellow,
University College London
Darren Hodgson
Executive Director,
Pharma
David Simpson
Professor of Genomics,
Queen's University Belfast
Davide Danovi
Director,
King's College London
Dhavendra Kumar
Honorary Clinical Professor,
William Harvey Research Institute, Queen Mary University London
Dmitrii Degtev
Senior Scientist,
AstraZeneca
Dmitry Shcherbo
Senior Bioinformatics Analyst,
Cancer Research UK Cambridge Institute
Douglas Drysdale
Partner,
HGF Limited
Evelyn Madoroba
Professor of Microbiology,
University Of Zululand
Frances Pearl
Senior Lecturer in Bioinformatics,
Univeristy of Sussex
Gabriel Rosser
Lead Bioinformatics Data Scientist,
Benevolent AI
Gareth Williams
Partner, European Patent Attorney,
Marks & Clerk LLP
George Hall
Research Fellow,
University College London
Graham Ball
Director,
Anglia Ruskin University
Graham Belfield
Director,
AstraZeneca
Hannah Stark
Operations Lead,
NIHR
Hanqing Liao
Senior Research Scientist,
Dundee University
Heiko Wurdak
Group Leader,
University of Leeds
Henry Cope
Research Bioinformatician,
The Royal Marsden NHS Foundation Trust
Hywel Williams
Senior Lecturer,
Cardiff University
Ines Sequeira
Group Leader,
Queen Mary University of London
Isar Nassiri
Senior Spatial Transcriptomics Computational Biologist,
University of Oxford
James Duboff
Strategic Partnerships Director,
Genomics England
Jan Lukas Robertus
Honorary Senior Clinical Lecturer,
Royal Brompton & Harefield NHS Foundation Trust
Jan-Philipp Mallm
Principal Investigator,
DKFZ
Janet Shipley
Head,
The Institute of Cancer Research
Jenna Cash
Principle Investigator,
University of Edinburgh
Jenna Bradley
Associate Principal Scientist in Target Validation,
AstraZeneca
Joey Riepsaame
Head of Genome Engineering Oxford,
Centre for Medicines Discovery
John Parrington
Associate Professor In Cellular & Molecular Pharmacology,
University of Oxford
John Le Quesne
Professor,
University of Glasgow
Jon Teague
Director of COSMIC,
Wellcome Trust Sanger Institute
Katherine Green
Patent Attorney,
Mewburn Ellis
Kathy Stirrups
Samples Team Lead,
NIHR BioResource for Translational Research
Kedar Natarajan
Associate Professor & Group Leader,
Technical University of Denmark
Ken Chow
Health Tech Counsel,
Flanders Investment & Trade, Belgium Embassy (London)
Kulbhushan Sharma
Principal Investigator,
Akershus University Hospital
Leo Carlin
Group Leader,
University of Glasgow
Manos Karteris
Reader,
Brunel University London
Marisa Vanheusden
Innovation Scientist,
Muna Therapeutics
Massimo Delledonne
Professor of Genetics,
University of Verona
Maté Ongenaert
Principal scientist,
Johnson & Johnson Innovative Medicine
Matthew Bottomley
Consultant Nephrologist & Research Group Lead,
Nuffield Department of Medicine, University of Oxford
Maximilian Schneider
Co-Founder and CTO,
Wholomics
Michael Rieger
Professor & Group Lead,
Goethe University of Frankfurt
Micol Falabella
Research Fellow,
University College London
Mohamed Abouelhoda
Chairman,
King Faisal Specialist Hospital & Research Centre
Nadiya Boyko
Professor,
Uzhnu
Nasrin Sarafan-Vasseur
Lead Scientist in Oncology,
University of Rouen
Naveed Ishaque
Group Leader for Computational Oncology,
Berlin Institute of Health at Charité University Hospital
Nektarios Liaskos
Data Community Coordinator,
EATRIS, the European Infrastructure for Translational Medicine
Neta Barashi
Chief Executive Officer,
Point6 bio
Nicola McCarthy
Head of Research,
Milner Therapeutics Institute
Omer Bayraktar
Group Leader,
Sanger Institute
Pamela Pinzani
Associate Professor,
University of Florence
Patrick Descombes
Senior Expert & Group Leader in Genomics,
Nestle
Peter Freeman
Lecturer in Healthcare Sciences (Clinical Bioinformatics, Genomics),
University of Manchester
Philip Beer
Chief Scientific Officer,
Step Pharma
Ramy Elgendy
Associate Principal Scientist, Centre for Genomics Research,
AstraZeneca
Richard D. Baird
Academic Consultant in Experimental Cancer Therapeutics,
University of Cambridge
Richard Magali
Chief Operating Officer,
One Biosciences
Rob Wolthuis
Associate Professor,
Amsterdam UMC Genome Diagnostics
Sergey Nikolaev
Group Lead,
Gustave Roussy Cancer Campus
Shameer Khader
Executive Director - Precision Medicine and Computational Biology,
Sanofi
Shani Perera
Technical Specialist,
Wellcome Sanger Institute
Simon McDade
Professor | Lead genomics CTU,
Queen's University Belfast
Simona Giunta
Associate Professor,
Sapienza University of Rome
Sophie Busson
Preclinical research scientist,
MeiraGTx
Stefano Indraccolo
Associate Professor,
University of Padova & IOV-IRCCS
Stephanie Craig
Lecturer in Precision Medicine,
Queen's University Belfast
Stephen Hart
Professor,
University College London
Stephen Taylor
Head of Integrative Computational Biology,
Oxford University
Sterenn Davis
Senior Principal Scientist,
Adaptimmune
Suresh Poovathingal
Head of Single Cell & Microfluidics Expertise Unit,
VIB KU Leuven Center for Brain & Disease Research
Valerie Taly
Group Leader,
University of Paris Descartes
Wei Wei
Associate Principal Scientist,
MSD
Wim Trypsteen
Senior Scientist,
Universiteit Gent
Yara Elena Sanchez Corrales
Research Fellow,
UCL
Yasser Riazalhosseini
Associate Professor,
McGill University
Yuval Tabach
Professor,
Hebrew University

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

In-Person Services Digital Marketing Services

Sponsors

Interested in Sponsoring NextGen Omics & Data 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Multi-Omics offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of medicine today.
Find Out More

New Opportunities

The Start-up Zone

Are you developing a cutting-edge therapy, platform or technology? Our Start-Up Zone is designed to support emerging companies looking to increase their visibility, find potential partners or early adopters, and meet their investment goals – connecting them with our community of pharma, investors, and mid-to-large size biotechs. 

Located in the Exhibition Hall, the Start-Up Zone allows therapeutic pioneers to showcase their approach, conduct invaluable 1:1 meetings and deliver a quick-fire pitch.

We offer two options starting from £1500 (+VAT), based on the size of your organisation. To get involved, apply today and our Start-Up Lead will be in touch to discuss further.

Criteria:

The Start-Up Zone is designed for therapeutic start-ups, academic spin-outs, and early-stage technology/service providers.

To be eligible for inclusion, you must meet the following criteria:

•    0 – 5 years operating
•    0 – 30 employees
•    Pre-Series A funding

Successful applicants will receive as part of their package:

•    1 full conference pass
•    10-minute pitch on the Start-Up Stage
•    1x1m space in Start-Up Zone: cocktail table provided, start-up to bring 1x pull-up banner
•    Logo featured on website & event platform as a participating start-up
•    Ability to arrange 1:1 meetings via to the congress app

2025 Young Scientist Awards (YSA) for Best Poster Presentation

The NextGen Biomed Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.

Please submit your poster presentation by no later than 13th January 2025 in the below category:

  • Protein/Antibody Engineering
  • Bioanalysis & Characterisation
  • Next Generation Biotherapeutics
  • Peptides Chemistry & Therapeutics
  • Oligonucleotides Chemistry & Therapeutics
  • Sustainable Chemistry & Manufacturing
  • Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
  • Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
  • ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA

Applicants must follow the procedure as follows: 

  • Register and submit an abstract by 13th January 2025 using the registration link to the left on this page 
  • Once registered you will be provided with the online abstract submission form 
  • Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.) 
  • The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event 
  • The winners’ 10-minute oral presentations will take place during the networking drinks on day 2 

The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the NextGen Biomed series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.

The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights. 

NextGen Biomed - New Opportunities YSA
LevitasBio

Highly relevant attendees which were encouraged to engage with vendors. I felt supported throughput the entire process.


Technical Account Manager
Levitasbio

Quantabio_logo

Really well organised event with a very supportive, present and friendly Oxford Global team.

Sales Specialist- UK, IR & Nordics
Quantabio

Agilent_Logo_Tag_v_RGB

 

Well organised with a good audience. Nice set up area for exhibitors.


Market Specialist
Agilent

Scienion_Logo

Fantastic conference, the Oxford Global staff are great.


Sales Manager UK and Ireland
Scienion

Plan Your Visit

Full details regarding accommodation, travel directions, health and safety, and other logistical information for the event will be added here in the coming months.

Interested in NextGen Omics & Data 2025?